Roth Capital Starts Repros Therapeutics (RPRX) at Buy
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $28.03 +0.18%
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
12 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Roth Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $19.00.
For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.
Shares of Repros Therapeutics closed at $13.91 yesterday.
For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.
Shares of Repros Therapeutics closed at $13.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts Americold Realty Trust (COLD) at Equal Weight
- Goldman Sachs Starts Victoria's Secret (VSCO) at Sell, 'Tough macro and ongoing competitive pressures'
- JPMorgan Starts Accent Group Ltd. (AX1:AU) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
